Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Authors: Yu Jeong Bang, Eduardo Yañez Ruiz, Eric Van Cutsem, Kuhn‐Uk Lee, Lucjan Wyrwicz, Michael Schenker, María Alsina, Min‐Hee Ryu, Hyun Cheol Chung, Ludovic Evesque, Salah-Eddin Al-Batran, Se Hoon Park, M. Lichinitser, Narikazu Boku, Markus Moehler, Janet Hong, Hua Xiong, Roland Hallwachs, Ilaria Conti, Julien Taı̈eb - Annals of Oncology 2018 cited by 503